Breast

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) MA.36 / Olympia / D081CC00006 / BIG 6-13 / NSABP B-55A randomised, double-blind, parallel group, placebo-controlled multi-centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapyBordeleau, Dr LouiseOpenNCT02032823
(CCTG) MA.37 / PALLAS / AFT – 05 / ABCSG 42 / BIG 14-03PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancerBordeleau, Dr LouiseOpenNCT02513394
(CCTG) MA.39Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast CancerWhelan, Dr TimothyOpenNCT03488693
(CCTG) MAC.20 / Alliance A011401Randomized Phase III Trial Evaluating the Role of Weight Loss In Adjuvant Treatment of Overweight and Obese Women with Early Breast CancerBordeleau, Dr LouiseOpenNCT02750826
(CCTG) MAC.23 / Alliance A221505 / RT CHARMPhase III Randomized Trial of Hypofractionated Post-Mastectomy Radiation with Breast ReconstructionKong, Dr IwaOpenNCT03414970
(HHS) RUBYReducing the burden of breast cancer in young womenHodgson, Dr NicoleOpenN/A
(HHS) SBRT Breast / STOMPStereotactic body radiotherapy (SBRT) for the Treatment of OligoMetastasis in breast cancer Patients (STOMP): A prospective feasibility trialDonovan, Dr ElysiaOpenNCT03295916
(JCC) ARTEMIS CK Breast StudyFeasibility Study of the Role of Stereotactic Body Radiotherapy for the Treatment of Early Stage Breast CancerKim, Dr Do-hoonOpenNCT02065960
OCOG-2016-DUCHESSEvaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients with Low/Intermediate Risk DCISKong, Dr IwaOpenNCT02766881
OCOG-2016-PETABCImpact of 18F-FDG PET-CT versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast CancerDhesy, Dr Bindi OpenNCT02751710
Download PDF